Cafepharma Today

January 28 2025 - Versant invests again in obesity, this time backing Helicore Biopharma
Versant invests again in obesity, this time backing Helicore Biopharma
Enhertu, with new FDA OK, set to supplant chemo in HER2-low breast cancer
Takeda regains home rights to phase 3-stage depression drug from Neurocrine
Stopwatch starts on reviews of GSK's long-acting asthma drug
*please scroll down for all the latest news*

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

*please scroll down for all the latest news*

Current News

submit a press release

Launches from Novo, Lilly top Clarivate's annual 'Drugs to Watch' list
Fierce Pharma
Wednesday, January 8, 2025 - 11:20pm
tags:
Novo Nordisk, Awiqli, insulin, CagriSema, Eli Lilly, Ebglyss
J&J Halts PFA Cases Amid Stroke Reports
Medical Devices and Diagnostics Industry
Wednesday, January 8, 2025 - 11:18pm
tags:
Medtech, JNJ, Varipulse, stroke, pulse field ablation
Scribe slims down workforce as it readies cardiometabolic genetic meds for clinic
Fierce Biotech
Wednesday, January 8, 2025 - 11:14pm
tags:
Scribe Therapeutics, cardiometabolic diseases, CRISPR
Phillips Medisize Boosts Medical Inhaler Portfolio With Vectura Acquisition
Medical Devices and Diagnostics Industry
Wednesday, January 8, 2025 - 11:11pm
tags:
Medtech, Phillips Medisize, M&A, Vectura Group
Medicare can now cover Eli Lilly’s Zepbound for sleep apnea, Health Department agency says
CNBC
Wednesday, January 8, 2025 - 11:07pm
tags:
Eli Lilly, Zepbound, Medicare, sleep apnea
Clinical trial trends in 2025: Investment headwinds, wearables, and targeted AI uses
Clinical Trials Arena
Wednesday, January 8, 2025 - 11:05pm
tags:
clinical trials, CROs, wearables, artificial intelligence
Tenvie unveils with $200M and a neuro pipeline with assets from Denali
Fierce Biotech
Wednesday, January 8, 2025 - 11:36am
tags:
Tenvie Therapeutics, Denali Therapeutics, neurological disorders
Alesta Therapeutics Raises €65 Million Series A Financing to Advance Oral Small Molecules for Rare Diseases
PR Newswire
Wednesday, January 8, 2025 - 11:33am
tags:
Alesta Therapeutics, funding, rare disease, small molecule drugs
Sana’s cell therapy may be ‘transformative cure’ for type 1 diabetes: analysts
Fierce Biotech
Wednesday, January 8, 2025 - 11:29am
tags:
Sana Biotechnology, cell therapy, type 1 diabetes, UP421
Roche to complete $1.5 billion acquisition of U.S. biopharma company Poseida
Pharma Live
Wednesday, January 8, 2025 - 11:25am
tags:
Roche, M&A, Poseida Therapeutics, blood cancer
Novo Nordisk doubles down on Valo, betting $190M near-term to apply AI to obesity and diabetes
Fierce Biotech
Wednesday, January 8, 2025 - 11:23am
tags:
Novo Nordisk, Valo Health, artificial intelligence, diabetes, obesity
LB Pharma's twist on old Sanofi drug passes schizophrenia test, teeing up phase 3 push
Fierce Biotech
Wednesday, January 8, 2025 - 11:19am
tags:
LB Pharma, schizophrenia, clinical trials, Sanofi, LB-102
HHS proposes HIPAA update to boost healthcare cybersecurity
Medtech Dive
Wednesday, January 8, 2025 - 11:18am
tags:
HHS, Medtech, HIPAA, cybersecurity
Cassava lays off 3rd of workforce in wake of phase 3 Alzheimer's fail
Fierce Biotech
Wednesday, January 8, 2025 - 11:17am
tags:
Cassava Sciences, layoffs, Alzheimer's disease, simufilam
3 trial readouts that could shake up the obesity market this year
Pharma Voice
Wednesday, January 8, 2025 - 11:15am
tags:
obesity, weight loss, Metsera, MET-097i, Skye Bioscience, nimacimab, Eli Lilly, orforglipron, clinical trials
Galapagos unveils plan to split, hiving off its drugs unit
Pharmaphorum
Wednesday, January 8, 2025 - 11:13am
tags:
Galapagos, restructuring, cell therapy
Vir Biotechnology Announces Encouraging Safety and Efficacy Data in Ongoing Dose Escalation Trials for Dual Masked T-Cell Engagers VIR-5818 in Solid Tumors and VIR-5500 in mCRPC
Stock Titan
Wednesday, January 8, 2025 - 11:12am
tags:
Vir Biotechnology, VIR-5818, solid tumors, VIR-5500, metastatic castration-resistant prostate cancer
Pharmaceuticals adding 'forever chemicals' to water supply
Beckers Hospital Review
Tuesday, January 7, 2025 - 7:07pm
tags:
environmental concerns, forever chemicals
Maze Therapeutics looks for IPO lodestar to guide kidney disease assets through clinical trials
Fierce Biotech
Tuesday, January 7, 2025 - 7:04pm
tags:
Maze Therapeutics, IPOs, kidney disease
Pfizer doubles down on AI partnership with antibody-drug conjugate deal
Chemical and Engineering News
Tuesday, January 7, 2025 - 7:03pm
tags:
Pfizer, antibody-drug conjugate, PostEra, artificial intelligence

Pages

Latest CP Wire Articles

FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies
Sapio Sciences launches new drug discovery platform
Bristol Myers Squibb Strengthens and Diversifies Oncology Portfolio With Acquisition of Mirati Therapeutics
Why Medical and Pharma Sales Reps Should Start Their Own Senior Care Business

Latest Pharmagather Articles

Drug Channels News Roundup, January 2025: Mark Cuban Fixes Healthcare, Payers’ G2N Bubble, Pharmacists Rejoice, 340B Shenanigans, and 46Brooklyn vs. Mushrooms
Drug Channels
Some Good MASH/NASH News For Once
In the Pipeline
Attacking Estrogen-Receptor-Positive Breast Cancer
In the Pipeline
New Study Reveals Five Crucial Priorities Shaping The Future of Patient Services
Drug Channels
Killing Cancer Patients (Once the Payments Clear)
In the Pipeline
The Big Three PBMs’ 2025 Formulary Exclusions: Humira, Stelara, Private Labels, and the Shaky Future for Pharmacy Biosimilars
Drug Channels
Clinical Trial Readouts Are A-Comin'
In the Pipeline
The Current Environment
In the Pipeline
Informa Connect's Patient Assistance & Access Programs (PAP)
Drug Channels

Latest Jobs

Pharmaceutical Sales Representative - Associate Territory Manager, Cardiometabolic Health
Tuscaloosa, Alabama
Eli Lilly and Company
Neuroscience Account Manager - Lancaster, PA
Lancaster, Pennsylvania, US
Lundbeck
Neuroscience Account Manager - Lancaster, PA
Lancaster, Pennsylvania, 17602
Lundbeck
Account Executive - Women's Health - W Palm Beach
Salt Lake City, Utah, 84101
Myriad Genetics
Pharmaceutical Sales Rep- Associate Territory Manager- Cardiometabolic Health
Tallahassee, Florida
Eli Lilly and Company
Psychiatry Account Manager - Atlanta East / Augusta, GA
Augusta, Georgia, US
Lundbeck
Sr. Training Manager Learning & Performance- Commercial Sales
Yardley, Pennsylvania, United States
EVERSANA
Psychiatry Account Manager - Billings, MT
Billings, Montana, US
Lundbeck
Neuroscience Account Manager - Indianapolis, IN
Indianapolis, Indiana, US
Lundbeck
Hybrid Pharmaceutical Sales Representative- EST/CST
Kansas City, Kansas, 66101
Amplity Health
more jobs

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.

Do Not Allow Advertisers to Use My Personal information